(Q38961557)

8 September 2017

title

Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells (English)

1 reference

8 September 2017

1 reference

Juanjuan Wu

1

1 reference

8 September 2017

Devin Williams

2

1 reference

8 September 2017

Grant A Walter

3

1 reference

8 September 2017

Winston E Thompson

4

1 reference

8 September 2017

Neil Sidell

5

1 reference

8 September 2017

language of work or name

English

0 references

publication date

27 August 2014

1 reference

Experimental Cell Research

8 September 2017

published in

1 reference

8 September 2017

volume

328

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

351-360

1 reference

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

An important role of Nrf2-ARE pathway in the cellular defense mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 signaling in coordinated activation of antioxidant gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2-Keap1 signaling pathway regulates human UGT1A1 expression in vitro and in transgenic UGT1 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

RU486-induced growth inhibition of human endometrial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Antagonists selective for estrogen receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

GSK-3 inhibitors induce chromosome instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Mechanisms of Nrf2/Keap1-dependent phase II cytoprotective and detoxifying gene expression and potential cellular targets of chemopreventive isothiocyanates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Repression of cancer protective genes by 17beta-estradiol: ligand-dependent interaction between human Nrf2 and estrogen receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Progesterone agonists and antagonists induce down– and up–regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

17β-estradiol regulates the expression of antioxidant enzymes in myocardial cells by increasing Nrf2 translocation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Arsenic-mediated activation of the Nrf2-Keap1 antioxidant pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

The consensus coding sequences of human breast and colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Somatic mutations of the KEAP1 gene in common solid cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2014.08.030

10.1016/J.YEXCR.2014.08.030

7 January 2021

Identifiers

DOI

1 reference

release_lnwjb3ovfrgjpezw6wcn6q4i5q

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lnwjb3ovfrgjpezw6wcn6q4i5q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference